Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 5939, 2024 03 11.
Article in English | MEDLINE | ID: mdl-38467806

ABSTRACT

In an era where environmental conservation is increasingly critical, identifying pathways through which technological innovations like virtual reality tourism (VRT) can promote sustainable behaviors is vital. This study investigates the impact of 'ecological presence', a newly proposed sub-dimension of presence in VRT, on tourists' environmentally responsible behavior (TERB). Through structural equation modeling and fuzzy set qualitative comparative analysis of data from 290 participants, we unveil that ecological presence-defined as the authenticity and immersion of tourists in virtual ecological environments-significantly bolsters biospheric values, environmental self-identity, and personal norms. Additionally, our findings indicate that ecological presence in VRT indirectly promotes TERB, predominantly through the mediation of enhanced biospheric values and environmental self-identity. Notably, ecological presence, biospheric values, and environmental self-identity constitutes a sufficient condition for achieving a high level of TERB. This research highlights the potential of VRT as an innovative tool for tourism administrators to foster environmental stewardship, offering a novel approach to leveraging technology for conservation efforts.


Subject(s)
Tourism , Virtual Reality , Humans , Administrative Personnel , Environment , Latent Class Analysis
2.
Nutrients ; 11(2)2019 Jan 23.
Article in English | MEDLINE | ID: mdl-30678114

ABSTRACT

Sophora species are used as dietary medicines in aging-associated symptoms. Sophora tomentosa L. (ST) is a native medicinal plant in Southeast Asia; however, there is no pharmacological literature about ST extract. The present study evaluates the antioxidant phytoconstituent contents and radical scavenging capacities of ST extract. The further investigation was to clarify the neuroprotective mechanism of ST extract against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism by assaying the activities of the dopaminergic system and antioxidant defenses, glycogen synthase kinase 3ß (GSK3-ß) phosphorylation, and α-synuclein levels in C57BL/6 mice. The results show that ST extract alleviated the motor deficits in MPTP-induced Parkinsonism with four behavioral tests, including a rearing locomotor, catalepsy test, balance beam walking test, and pole test. ST extract reversed the number of tyrosine hydroxylase (TH)-positive neurons in substantia nigra (SN) that had decreased by MPTP. ST extract also restored the decreased levels of dopamine and the expression of tyrosine hydroxylase (TH) in the striatum. Furthermore, ST extract restored the levels of glutathione (GSH) and the activities of antioxidant enzymes, and decreased the elevated levels of malondialdehyde (MDA) in mouse striatum. ST extract also decreased α-synuclein overexpression and GSK-3ß phosphorylation in mouse striatum. In vitro, ST extract exerted higher 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical scavenging capacities through its higher phenolic contents, especially protocatechuic acid and epicatechin. These results suggest that ST extract has the potential to counteract MPTP-induced motor deficit. The neuroprotective mechanism of ST extract against MPTP-induced Parkinsonism might be related to decreasing GSK-3ß phosphorylation and restoring the activities of striatal antioxidant defenses to restore the nigrostriatal dopaminergic function and decrease α-synuclein accumulation.


Subject(s)
Glycogen Synthase Kinase 3 beta/metabolism , Parkinsonian Disorders/metabolism , Plant Extracts/pharmacology , Signal Transduction/drug effects , Sophora/chemistry , 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/adverse effects , Animals , Disease Models, Animal , Male , Mice , Mice, Inbred C57BL , Oxidative Stress/drug effects , Phosphorylation/drug effects
3.
J Neurol Sci ; 202(1-2): 35-41, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12220690

ABSTRACT

In this study, we investigated the dose-effect relationship and safety of tissue plasminogen activator (tPA) for the treatment of intraventricular hemorrhage/hematoma (IVH) in rats. Adult male Sprague-Dawley rats were injected with autologous blood into the left lateral ventricle to establish IVH. Two hours later, Ringer's saline or 0.25-2 microg of tPA were administered directly to the IVH over 3 h. The regional cerebral blood flow (rCBF) on the surface of the left parietal cortex was measured with laser Doppler flowmetry. Twenty-four hours after the build-up of IVH, the brains were removed for morphometrical and histological studies. A dose of 0.5-2 microg tPA significantly diminished the IVH in a dose-dependent manner (p < 0.001). However, only the dose of 0.5 microg tPA significantly ameliorated the reduction of rCBF 24 h after IVH (p < 0.01). TPA did not improve the ventricular dilatation on the side with IVH. Instead, 1-2 microg of tPA caused additional injuries, including intraventricular leukocytosis and edema of periventricular tissues and choroid plexus on both hemispheres. These results indicate that higher doses of tPA may have detrimental effects on the brain. The dosage rate of 0.5 microg seems beneficial to treat 5 microl of IVH (equals to a dose of 0.1 mg/ml blood) in our model in terms of the satisfactory fibrinolysis and less damage to the brain.


Subject(s)
Cerebral Hemorrhage/drug therapy , Hematoma/drug therapy , Tissue Plasminogen Activator/administration & dosage , Animals , Brain Edema/chemically induced , Cerebral Hemorrhage/pathology , Cerebral Hemorrhage/physiopathology , Dose-Response Relationship, Drug , Hematoma/pathology , Hematoma/physiopathology , Injections, Intraventricular , Laser-Doppler Flowmetry , Lateral Ventricles/drug effects , Lateral Ventricles/pathology , Leukocytosis/chemically induced , Male , Parietal Lobe/blood supply , Parietal Lobe/drug effects , Parietal Lobe/pathology , Parietal Lobe/physiopathology , Rats , Rats, Sprague-Dawley , Tissue Plasminogen Activator/adverse effects , Tissue Plasminogen Activator/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...